Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments.
published in: Expert Opinion on Pharmacotherapy
date of publication: 2014-03-04
language: English
main subject: lupus erythematosus, systemic lupus erythematosus
Cites articles 41
- 2011-12-01
- 2008-08-21
Date
Title
Article - wd:Q38192725